A detailed history of Capital Asset Advisory Services LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 3,566 shares of EXAS stock, worth $214,316. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,566
Holding current value
$214,316
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$42.43 - $70.83 $151,305 - $252,579
3,566 New
3,566 $242,000
Q3 2023

Oct 18, 2023

BUY
$65.94 - $99.04 $15,429 - $23,175
234 Added 7.25%
3,463 $236,000
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $152,376 - $228,516
3,229 New
3,229 $218,000
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $1,981 - $2,635
-17 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$99.61 - $142.12 $1,693 - $2,416
17 New
17 $2,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.6B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Capital Asset Advisory Services LLC Portfolio

Follow Capital Asset Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.